PhD Duško Lainšček

PhD Duško Lainšček
no.: 34069 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
4.06.02  Biotechnical sciences  Biotechnology  Bio-engineering 
3.01.00  Medical sciences  Microbiology and immunology   
Keywords
genome engineering, CRISPR, cell and gene therapy
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
672.33
A''
314.69
A'
512.97
A1/2
606.65
CI10
874
CImax
124
h10
16
A1
2.74
A3
1.23
Data for the last 5 years (citations for the last 10 years) on November 10, 2025; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 45  933  826  18.36 
Scopus 42  978  864  20.57 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 Jelica Pantović Žalig   Bologna doctoral studies    55818 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (50%, RD:50%)  National Institute of Chemistry  Department of Synthetic Biology and Immunology 
Full time employment (50%, RD:50%)  National Institute of Chemistry  Center za tehnologije genske in celične terapije (Slovene) 
Full time employment (10%, RD:10%)  EN-FIST CENTRE OF EXCELLENCE  RS EN-FIST (Slovene) 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. GC-0005  Bridging oligonucleotide-based therapeutic upregulation of translation (BOOST)   7/1/2025 - 6/30/2028  PhD Roman Jerala   7,710 
2. J3-60061  Development of Phosphorylation-targeting Switchable CAR-T Designs for Enhanced Safety and Efficacy   1/1/2025 - 12/31/2027  PhD Mojca Benčina   1,701 
3. J3-60056  NINJACURE: Cutting-edge inflammation and cancer treatment based on Ninjurin-1-mediated plasma membrane rupture   1/1/2025 - 12/31/2027  PhD Iva Hafner Bratkovič   2,323 
4. N4-0424  BECoil  – improving base editing specificity and efficiency by dynamic coupling between targeting and editing subunits   9/1/2025 - 2/28/2027  PhD Roman Jerala   1,346 
5. J1-4406  CC-Trigger: toehold mediated protein coiled-coil displacement to introduce kinetic control of protein assemblies and advanced multi-state devices.   10/1/2022 - 9/30/2025  PhD Ajasja Ljubetič   1,767 
6. J3-4526  Chimeric Autologous Vaccine against PCSK9   10/1/2022 - 9/30/2025  PhD Aleš Blinc   3,585 
7. J7-4537  GENOTYPE-PHENOTYPE CORRELATION STUDY OF CTNNB1 SYNDROME AND INVESTIGATION OF NOVEL APPROACHES TO ITS TREATMENT   10/1/2022 - 9/30/2025  PhD Damjan Osredkar   2,215 
8. J7-4640  Innovative CAR T cell cancer immunotherapy (CARRS)   10/1/2022 - 9/30/2025  PhD Roman Jerala   4,549 
9. J4-4563  Non-viral engineering of CAR-T cells using an enhanced version of a CRISPR/Cas system   10/1/2022 - 9/30/2025  PhD Duško Lainšček   1,633 
10. J1-4408  Ultrasound signaling cascade with calcium positive feedback loop as a signal amplifier for transient activation of chimeric antigen receptors for cancer immunotherapy   10/1/2022 - 9/30/2025  PhD Mojca Benčina   1,777 
11. V4-2038  DNA vaccine and peptide inhibitors against SARS-CoV-2   10/1/2020 - 9/30/2022  PhD Roman Jerala   8,795 
12. N4-0080  Optimizacija sinteznobioloških genskih vezij in reprogramiranja celic s pomočjo mikrofluidike (Slovene)   1/1/2018 - 12/31/2021  PhD Roman Jerala   1,597 
13. J3-9268  Cancer immunotherapy modulation by ultrasound   7/1/2018 - 6/30/2021  PhD Mojca Benčina   1,846 
14. Z3-9276  Regulation of the therapeutic effect of CAR-T cells for increased safety and efficiency   7/1/2018 - 6/30/2020  PhD Duško Lainšček   194 
15. J3-8196  Medcelični prenos signalnega kompleksa z izvenceličnimi vezikli, ki se sproščajo iz celic, ki nosijo z WM-povezano mutacijo v MyD88 (Slovene)   5/1/2017 - 4/30/2020  PhD Mateja Manček Keber   2,299 
16. J3-7034  Advanced nano-vaccines based on protein origami combining activators of innate and adaptive immune response   1/1/2016 - 12/31/2018  PhD Mojca Benčina   2,566 
17. J3-6784  Molekularni mehanizem signalizacije enoverižne DNA preko znotrajceličnega Tollu-podobnega receptorja 9 (Slovene)   7/1/2014 - 6/30/2017  PhD Mojca Benčina   2,427 
18. J3-6791  Sintezno biološki pristop k celjenju ran in nevroregeneraciji (Slovene)   7/1/2014 - 6/30/2017  PhD Iva Hafner Bratkovič   2,359 
19. J3-5503  DOLOČITEV MEHANIZMA VNETJA V CENTRALNEM ŽIVČNEM SISTEMU ZA INOVATIVNO TERAPIJO NEVRODEGENERATIVNIH BOLEZNI (Slovene)   8/1/2013 - 7/31/2016  PhD Iva Hafner Bratkovič   3,496 
20. N5-0003  SYNTOLL - Re-inženiring signalnega omrežja sesalske celice (Slovene)   7/1/2010 - 6/30/2013  PhD Roman Jerala   2,319 
21. J1-2271  Znotrajcelični Tollu podobni receptorji in vpliv inhibicije receptorjev TLR pri avtoimunih boleznih (Slovene)   5/1/2009 - 4/30/2012  PhD Mojca Benčina   1,747 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P4-0176  Synthetic biology and immunology   1/1/2022 - 12/31/2027 PhD Roman Jerala   2,565 
2. P4-0176  Molecular Biotechnology: from the Dynamics of Biological Systems to Applications   1/1/2015 - 12/31/2021 PhD Roman Jerala   3,220 
3. P4-0176  Molecular Biotechnology: from Dynamics of Biological Systems to Applications   1/1/2009 - 12/31/2014 PhD Roman Jerala   3,527 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite